©2022 Stanford Medicine
HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)
Not Recruiting
Trial ID: NCT01456000
Purpose
The purpose of this study is to demonstrate the safety and effectiveness of the CardioFocus
Endoscopic Ablation System with Adaptive Contact (HeartLight) in the treatment of atrial
fibrillation by creating electrical isolation of the pulmonary veins.
Official Title
Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Eligibility
Inclusion Criteria:
- 18 to 75 years.
- paroxysmal atrial fibrillation
- failure of at least one AAD
- others
Exclusion Criteria:
- overall good health as established by multiple criteria
Intervention(s):
device: EAS-AC (HeartLight)
procedure: Control Arm Ablation
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Gerri O'Riordan
650-725-5597